Arbutus, Barinthus Combo Achieves Functional Cure in Hep B

 50% of patients who had baseline HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial

Overall, in Cohort A1, 25% of patients achieved functional cure

Data to be presented in late-breaker poster session at AASLD – The Liver Meeting® on Monday, November 18, 2024

https://www.globenewswire.com/news-release/2024/11/15/2982137/14025/en/Arbutus-Imdusiran-Achieves-Functional-Cure-in-cHBV-Patients-when-Combined-with-a-Short-Course-of-Interferon.html